Search

21. Action level for inorganic arsenic in apple juice: guidance for industry

Publication:

College Park, MD : Center for Food Safety and Applied Nutrition, June 2023

Subject(s):

Arsenic
Food Safety
Food Supply
Government Regulation
United States

22. Acute myeloid leukemia: developing drugs and biological products for treatment : guidance for industry

Publication:

Silver Spring, MD : Center for Drug Evaluation and Research, October 2022

Subject(s):

Biological Products
Drug Development -- legislation & jurisprudence
Government Regulation
Leukemia, Myeloid, Acute -- drug therapy
United States
United States. Food and Drug Administration

23. Adaptive designs for clinical trials of drugs and biologics

Publication:

Silver Spring, MD : Center for Drug Evaluation and Research, November 2019

Subject(s):

Adaptive Clinical Trials as Topic -- standards
Investigational New Drug Application
Adaptive Clinical Trials as Topic -- ethics
Biological Products
Drugs, Investigational
Research Design
Humans
United States
United States. Department of Health and Human Services.
United States. Food and Drug Administration.

24. Addressing social determinants of health: examples of successful evidence-based strategies and current federal efforts

Author(s):

Whitman, Amelia, author
De Lew, Nancy, author
Chappel, Andre, author
Aysola, Victoria, author
Zuckerman, Rachael, author

Publication:

[Washington, D.C.] : Department of Health and Human Services, Office of the Assistant Secretary for Planning and Evaluation, Office of Health Policy, April 1, 2022

Subject(s):

Delivery of Health Care, Integrated
Evidence-Based Practice
Federal Government
Social Determinants of Health
United States

25. Addressing the direct care workforce shortage: a bipartisan call to action

Publication:

Washington, DC : Bipartisan Policy Center, December 2023

Subject(s):

Emigrants and Immigrants
Government Regulation
Health Policy
Health Workforce
Home Care Services
Home Health Aides
Home Health Nursing
Medicare
United States

26. Adjusting for covariates in randomized clinical trials for drugs and biological products: guidance for industry

Publication:

Silver Spring, MD : Center for Drug Evaluation and Research, May 2023

Subject(s):

Biological Products
Drug Industry
Government Regulation
Pharmaceutical Preparations
Randomized Controlled Trials as Topic
United States

27. Administrative procedures for CLIA categorization: guidance for industry and Food and Drug Administration staff

Publication:

Silver Spring, MD : Center for Devices and Radiological Health, October 2, 2017

Subject(s):

Clinical Laboratory Techniques
Device Approval -- standards
Diagnostic Test Approval -- standards
In Vitro Techniques -- standards
Reagent Kits, Diagnostic -- standards
Humans
United States
United States. Department of Health and Human Services.
United States. Food and Drug Administration.

28. Adolescent and young adult substance use: federal grants for prevention, treatment, and recovery services and for research : report to Congressional committees

Publication:

Washington, DC : United States Government Accountability Office, September 2018

Subject(s):

Financing, Government
Substance-Related Disorders -- prevention & control
Adolescent
Young Adult
United States
United States. Department of Education.
United States. Department of Health and Human Services.
United States. Department of Justice.

29. Advance care planning among Medicare fee-for-service beneficiaries and practitioners: final report

Author(s):

He, Fang, author
Gasdaska, Angela, author
Friedman, Hannah, author
Wedehas, Brendan, author
Kirk, Alexis, author
Broyles, Ila, author
Karon, Sarita L., author

Publication:

[Washington, D.C.] : United States Department of Health and Human Services, Office of the Assistant Secretary for Planning and Evaluation, September 2020

Subject(s):

Advance Care Planning
Medicare
Fee-for-Service Plans
United States

30. Advanced prostate cancer: developing gonadotropin-releasing hormone analogues

Publication:

Silver Spring, MD : Center for Drug Evaluation and Research, May 2022

Subject(s):

Drug Development -- legislation & jurisprudence
Gonadotropin-Releasing Hormone
Prostatic Neoplasms -- drug therapy
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration

31. Advancement of emerging technology applications for pharmaceutical innovation and modernization

Publication:

Silver Spring, MD : Center for Drug Evaluation and Research, September 2017

Subject(s):

Biomedical Technology -- standards
Drug Industry -- standards
Inventions
Quality Assurance, Health Care
Quality Improvement
Humans
United States
United States. Department of Health and Human Services.
United States. Food and Drug Administration.

32. Advancing comprehensive primary care in Medicaid

Publication:

Washington, DC : Bipartisan Policy Center, July 2020

Subject(s):

Medicaid -- legislation & jurisprudence
Medicaid -- organization & administration
Medicaid -- standards
Primary Health Care
Healthcare Disparities
Insurance, Health
United States

33. Advancing primary prevention in human services. Key considerations for administrators and practitioners

Author(s):

Akers, Lauren, author
Tippins, Jennifer Laura, author
Hauan, Susan, author
Lynch-Smith, Miranda, author

Publication:

Washington, D.C. : Office of the Assistant Secretary for Planning and Evaluation, Office of Human Services Policy, June 2023

Subject(s):

Primary Prevention -- organization & administration
Social Welfare
Social Work
United States

34. Advancing primary prevention in human services. Key considerations for policy designers and funding partners

Author(s):

Akers, Lauren, author
Tippins, Jennifer Laura, author
Hauan, Susan, author
Lynch-Smith, Miranda, author

Publication:

Washington, D.C. : Office of the Assistant Secretary for Planning and Evaluation, Offices of Human Services Policy, June 2023

Subject(s):

Primary Prevention -- organization & administration
Health Policy
Social Welfare
Social Work
United States

35. Advancing primary prevention in human services. Opportunities for people with lived experience

Author(s):

Akers, Lauren, author
Tippins, Jennifer Laura, author
Hauan, Susan, author
Lynch-Smith, Miranda, author

Publication:

Washington, D.C. : Office of the Assistant Secretary for Planning and Evaluation, Office of Human Services Policy, June 2023

Subject(s):

Community Participation
Primary Prevention -- organization & administration
Social Welfare
Social Work
United States

36. Advancing primary prevention in human services: convening findings

Author(s):

Akers, Lauren, author
Tippins, Jennifer Laura, author
Hauan, Susan, author
Lynch-Smith, Miranda, author

Publication:

Washington, D.C. : Office of the Assistant Secretary for Planning and Evaluation, Offices of Human Services Policy, March 2023

Subject(s):

Community Support
Ill-Housed Persons
Poverty
Primary Prevention
Social Support
Social Work -- organization & administration
United States

37. Adverse events in hospitals. A quarter of Medicare patients experienced harm in October 2018

Publication:

Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, May 2022

Subject(s):

Government Regulation
Hospitals
Medicare
Patient Harm -- prevention & control
Patient Harm -- statistics & numerical data
Patient Safety
United States

38. Adverse events in long-term-care hospitals: national incidence among Medicare beneficiaries

Publication:

[Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, November 2018

Subject(s):

Hospitals -- statistics & numerical data
Incidence
Long-Term Care -- statistics & numerical data
Medical Errors -- statistics & numerical data
Medicare
Hospital Mortality
Medical Errors -- prevention & control
Patient Safety
Quality Indicators, Health Care
Quality of Health Care
Subacute Care
Humans
United States
United States. Agency for Healthcare Research and Quality.
Centers for Medicare & Medicaid Services (U.S.)

39. Adverse events toolkit. Clinical guidance for identifying harm

Publication:

Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, July 2023

Subject(s):

Evaluation Studies as Topic
Government Regulation
Medical Errors
Patient Harm
Risk Management
United States

40. Adverse events toolkit. Medical record review methodology

Publication:

Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, July 2023

Subject(s):

Evaluation Studies as Topic
Government Regulation
Medical Errors
Medical Records
Patient Harm
Risk Management
United States